Skip to main content
Equibles

BOOTHBAY FUND MANAGEMENT, LLC

Position in PRQR — ProQR Therapeutics N.V.

CIK 1549230 NEW YORK, NY
Back to PRQR Full portfolio

Position in PRQR

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$1,764,648
+$1,189,090 QoQ
Shares Held
948,736
+167.0% QoQ
Ownership
0.672%
of shares outstanding
% of Portfolio
0.03%
of 13F equity value
Holder Rank
#18
of 69 holders
Holding Since
Jun 2021
17 quarters on record
Voting authority Sole 0% Shared 100% None 0%

Common Shares in PRQR Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

BOOTHBAY FUND MANAGEMENT, LLC holds $666,641,771 across 159 Biotechnology names. PRQR ranks #73 (0.3% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 RVMD
Revolution Medicines, Inc.
 465,787 $87,232,589
2 ABVX
Abivax S.A.
 563,367 $75,074,286
3 EXEL
Exelixis, Inc.
 804,095 $43,750,808
4 PCVX
Vaxcyte, Inc.
 534,163 $31,050,895
5 COGT
Cogent Biosciences, Inc.
 692,825 $26,812,327
6 CGEM
Cullinan Therapeutics, Inc.
 1,082,611 $19,714,346
7 TNGX
Tango Therapeutics, Inc.
 500,497 $15,645,536
8 AVTX
Avalo Therapeutics, Inc.
 702,051 $12,973,902

All Filings in PRQR

Export CSV
17 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $1,764,648 948,736
2026-03-31 $575,558 355,283
2025-12-31 $717,671 355,283
2025-09-30 $528,857 248,290
2025-06-30 $457,225 224,130
2025-03-31 $298,092 224,130
2024-12-31 $689,731 260,276
2024-09-30 $194,199 106,703
2024-06-30 $177,126 106,703
2024-03-31 $244,349 106,703
2023-12-31 $189,575 95,745
2023-09-30 $124,468 95,745
2023-06-30 $155,106 95,745
2023-03-31 $203,936 95,745
2022-12-31 $334,054 90,285
2021-09-30 $152,258 18,191
2021-06-30 $258,869 38,408